Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional 5-fluorouracil for basal cell carcinoma
IRCT20200205046380N2Phase 2Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of fluorouracil in basal cell carcinoma (BCC), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Lesion size, Lesion pathology and 11 more. Started Apr 2020; status: completed.
02
Drugs
fluorouracil
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on IRCT20200205046380N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200205046380N2.